Sign in

Daria Van Tyne

@dariavantyne.bsky.social
2.2K followers 1K following 31 posts

Microbiology, evolution, and bacteriophages. University of Pittsburgh School of Medicine.

PostsRepliesMedia
Daria Van Tyne @dariavantyne.bsky.social · 22/09/2026
My lab at Pitt is looking for a Laboratory Technician to help our research and phage therapy efforts. Please share and apply! cfopitt.taleo.net/careersectio...
cfopitt.taleo.net
Laboratory Technician
Click the link provided to see the complete job description.
0824
Reposted by Daria Van Tyne
Pitt Program in Microbiology & Immunology @pitt-pmi.bsky.social · 07/08/2026
Congratulations to @nathaliechen.bsky.social from the @dariavantyne.bsky.social lab on her upcoming PhD thesis defense! 🎈👏
Nathalie Chen will defend her PhD dissertation entitled "Differential virulence potential of different clades of multidrug-resistant Klebsiella pneumoniae ST258" on August 18, 2026 at 11 am in Scaife Hall.
181
Daria Van Tyne @dariavantyne.bsky.social · 30/07/2026
Happy to share some recent "summer science" papers from our lab. First, former graduate student @emmamills1.bsky.social's second dissertation paper on culture-enriched metagenomics of VREfm was published in Microbial Genomics @microbiologysociety.org www.microbiologyresearch.org/content/jour...
microbiologyresearch.org
Culture-enriched metagenomic sequencing reveals within-patient diversity and transmission of vancomycin-resistant Enterococcus faecium
Colonization of the gastrointestinal (GI) tract by vancomycin-resistant Enterococcus faecium (VREfm) often precedes bloodstream infection and serves as a reservoir for onward patient transmission in h...
193
Reposted by Daria Van Tyne
Vaughn Cooper @vscooper.micropopbio.org · 29/06/2026
Important results of collab led by ⭐surgeon-microbiologist Ken Urish w/ @dariavantyne.bsky.social @ironark.bsky.social and us: Chronic suppression of a multidrug-resistant Pseudomonas aeruginosa in prosthetic joint infection using personalized bacteriophage treatment www.nature.com/articles/s41...
nature.com
Chronic suppression of a multidrug-resistant Pseudomonas aeruginosa in prosthetic joint infection using personalized bacteriophage treatment - Nature Communications
This work reports the clinical outcomes of bacteriophage therapy for a recalcitrant Pseudomonas aeruginosa periprosthetic joint infection, demonstrating infection control through biofilm disruption an...
0179
Daria Van Tyne @dariavantyne.bsky.social · 11/06/2026
Phages to the rescue! @pghphageprogram.bsky.social @idpittstop.bsky.social
0132
Daria Van Tyne @dariavantyne.bsky.social · 02/06/2026
We submitted this proposal in January 2025 and it was finally funded! Grateful and excited to keep working to bring phage therapy out of the laboratory and into the clinic. @pghphageprogram.bsky.social www.medschool.pitt.edu/news/pitt-ce...
medschool.pitt.edu
Pitt Center Is Part of First NIH-Funded Coordinated Research Network for Phage Therapeutics | School of Medicine | University of Pittsburgh
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded three new Centers for Accelerating Phage Therapy to Combat ESKAPE Pathogens (CAPT-CEP)—the first coordinated U.S. research...
2399
Daria Van Tyne @dariavantyne.bsky.social · 08/04/2026
My lab at Pitt is looking for a Research Scientist to help us make phage therapy for patients with antibiotic-resistant infections. Please share and apply! cfopitt.taleo.net/careersectio...
cfopitt.taleo.net
Research Scientist
Click the link provided to see the complete job description.
07075
Reposted by Daria Van Tyne
Pittsburgh Phage Program @pghphageprogram.bsky.social · 02/04/2026
Drug-resistant infections are rising—and we need new solutions. Phage therapy uses viruses that target & kill harmful bacteria with precision 🦠 At P3, we’re bringing this innovation to patients who need it most. 🔗 www.futureofpersonalhealth.com/infectious-d... #pittsburghphageprogram #phagetherapy
futureofpersonalhealth.com
Drug-Resistant Infections Are Rising. Phage Therapy Can Help Stop Them.
Antibiotic-resistant infections are outpacing the drug pipeline, but a powerful, targeted solution has existed in nature all along.
031
Reposted by Daria Van Tyne
Tami Lieberman @contaminatedsci.bsky.social · 18/03/2026
If you're a senior PhD student or recent graduate interested in doing work at the intersection of AI and microbial genomics and/or microbiomes, please feel free to reach out to discuss the possibility of applying together for an MIT Novo Nordisk Fellowship engineering.mit.edu/novo-nordisk
engineering.mit.edu
Novo Nordisk Fellowship
Potential areas of focus for postdoctoral fellows participating in the MIT-Novo Nordisk Postdoc Program include, but are not limited to, the following: Your complete application should include: In the...
12632
Daria Van Tyne @dariavantyne.bsky.social · 17/03/2026
Two new studies from us using culture-enriched metagenomics to study populations (not just clones!) of some of our favorite superbugs collected from infected patients in the hospital 🧵
1123
Daria Van Tyne @dariavantyne.bsky.social · 04/03/2026
This was so much fun! Check out Jess’s thread and the podcast to hear how we “do” phage therapy these days @pghphageprogram.bsky.social
022
Reposted by Daria Van Tyne
Keystone Symposia @keystonesymposia.bsky.social · 27/02/2026
⏰ Last chance to save $250! Register for Beyond Antibiotics by 11:59pm MST on March 5. Join @joeyzacks.bsky.social, @kimingeneva.bsky.social, @dariavantyne.bsky.social & @maribyndloss.bsky.social to spark new collaborations. 🎥 youtu.be/8Ppjx-MnvxA keysym.us/KSBeyondAnti... #KSBeyondAntibiotics26
youtu.be
KSQA: Drs. Joseph P. Zackular & Mariana X. Byndloss (Beyond Antibiotics)
YouTube video by KeystoneSymposia
145
Reposted by Daria Van Tyne
Vaughn Cooper @vscooper.micropopbio.org · 09/01/2026
🚨Call for papers🚨 Microbial Evolution: Impacts on Human Health in the society journal Evolution, Medicine, and Public Health Guest Editors: Bob Woods, Silvie Huijben & Camilo Barbosa EIC: me This will be great, please submit and share! academic.oup.com/emph/pages/m...
Microbial Evolution: Impacts on Human Health

Call for Papers

A defining characteristic of infectious diseases is that they evolve. The consequences of this evolution are among the most pressing medical issues facing humanity, including emerging pandemics, antibiotic resistance, and the success or failure of vaccines. Pathogen evolution profoundly influences virulence, transmission, and responses to a broad array of human interventions. While the evolutionary dynamics of pathogens have historically been challenging to study, large-scale genomic sequencing, novel computational tools, and experimental methods are rapidly changing the field. We encourage submissions on the broad topic of the evolution of infectious diseases.

This Special Issue aims to feature research that blends evolutionary approaches to understanding pathogen heterogeneity and ongoing genetic change in clinical samples and models of human infection. It also seeks to highlight opportunities to design treatment and prevention strategies that remain effective in the face of ongoing pathogen evolution.

Submission – open until January 31, 2027

Guest editors
Robert Woods, MD PhD, University of Michigan
Camilo Barbosa, PhD, University of Michigan 
Silvie Huijben, PhD, Arizona State University
22537
Daria Van Tyne @dariavantyne.bsky.social · 06/01/2026
Submission deadline for short talks and scholarships is Wednesday! Come join us in Breckenridge in May!
010
Daria Van Tyne @dariavantyne.bsky.social · 23/12/2025
So incredibly proud of this work, and thankful to everyone who makes it possible!
2112
Daria Van Tyne @dariavantyne.bsky.social · 20/12/2025
From our lab to yours, Happy Holidays!!
Holiday card with cookies shaped like microbes
1110
Reposted by Daria Van Tyne
Kimberly Kline 🏔 @kimingeneva.bsky.social · 04/11/2025
We're just 6 months away from @keystoneSymposia.bsky.social Beyond #Antibiotics : Emerging Strategies Combating #BacterialInfection, May 2026 in Breckenridge! 👉Scholarship and short talk abstract deadlines are Jan 7! 🧐 keysym.us/KSBeyondAntibiotics26 #KSBeyondAntibiotics26
keysym.us
Beyond Antibiotics: Emerging Strategies for Combating Bacterial Infection | Keystone Symposia
Join us at the Keystone Symposia on Beyond Antibiotics: Emerging Strategies for Combating Bacterial Infection, May 2026, in Breckenridge, with field leaders!
21814
Daria Van Tyne @dariavantyne.bsky.social · 09/05/2025
Come join us in Breckenridge next May!
042
Reposted by Daria Van Tyne
Jesse Shapiro @bjesseshapiro.bsky.social · 24/04/2025
Come join us at @mcgill.ca as an assistant professor in virus-host interactions! Please share widely. mcgill.wd3.myworkdayjobs.com/en-US/McGill...
mcgill.wd3.myworkdayjobs.com
Assistant Professor (Research), Department of Microbiology & Immunology, (C2-240724)
Please refer to the How to Apply for a Job (for External Candidates) job aid for instructions on how to apply. If you are an active McGill employee (ie: currently in an active contract or position at ...
16391
Reposted by Daria Van Tyne
Pittsburgh Phage Program @pghphageprogram.bsky.social · 09/04/2025
Big shoutout to @olayarendueles.bsky.social @julielebris.bsky.social , @nathaliechen.bsky.social, @dariavantyne.bsky.social and Adeline Supandy—such an awesome team effort from the #VanTyneLab at Pitt! 💫 Great to see phage work move forward together! #PittsburghPhageProgram
061
Reposted by Daria Van Tyne
Pittsburgh Phage Program @pghphageprogram.bsky.social · 07/04/2025
🔬 The spotlight continues! We’re excited to introduce the next incredible member of the #PittsburghPhageProgram team — meet Dr. @dariavantyne.bsky.social, whose work is helping push the boundaries of what’s possible in #phagetherapy. #InfectiousDiseases #P3 #VanTyneLab
071
Reposted by Daria Van Tyne
Pittsburgh Phage Program @pghphageprogram.bsky.social · 28/03/2025
Behind every patient story, every discovery, and every #phage, there’s a dedicated team making it happen. Over the next few weeks, we’re excited to introduce the people who power the #PittsburghPhageProgram — starting with Dr. Ghady Haidar.🧫✨
181
Reposted by Daria Van Tyne
Nature @nature.com · 26/03/2025
Emerging strains of a deadly ‘superbug’ seem to have picked up an advantage over other micro-organisms: a chemical weapon that kills competing bacteria go.nature.com/4lb8279
go.nature.com
A superbug rose to the top after gaining a chemical weapon
A newfound ability to produce an antibiotic helped a strain of antibiotic-resistant bacteria to take over a hospital.
13318
Reposted by Daria Van Tyne
Pittsburgh Phage Program @pghphageprogram.bsky.social · 21/03/2025
Shoutout to @dariavantyne.bsky.social, our Head of Phage Biology and Discovery, for her leadership in #phagetherapy. P3's latest clinical impact was given the spotlight in Contagion Live! Read more on how phage therapy is transforming treatment options: 🔗 tinyurl.com/Contagion-Live
052
Daria Van Tyne @dariavantyne.bsky.social · 21/03/2025
Excited to share our latest, out today in @naturemicrobiol.bsky.social Bacteriocin production facilitates nosocomial emergence of vancomycin-resistant Enterococcus faecium www.nature.com/articles/s41... @idpittstop.bsky.social
nature.com
Bacteriocin production facilitates nosocomial emergence of vancomycin-resistant Enterococcus faecium - Nature Microbiology
Genomic and functional analyses of healthcare-associated vancomycin-resistant Enterococcus faecium reveal that bacteriocin T8 is enriched in emergent lineages and provides a competitive advantage in v...
1311154
Reposted by Daria Van Tyne
Pittsburgh Phage Program @pghphageprogram.bsky.social · 19/03/2025
👋 We're the Pittsburgh Phage Program (P3)! Based at Pitt, we advance precision medicine using phages—viruses that kill bacteria. We fight antibiotic resistance through compassionate use & clinical trials. Follow for 🔬research, 💡phage facts, 📢success stories! #PhageTherapy #P3
0174
Reposted by Daria Van Tyne
Vaughn Cooper @vscooper.micropopbio.org · 11/02/2025
How does avi-caz treatment lead to broad-spectrum treatment failure? Our awesome Peds ID faculty and labbie @rapskiid.bsky.social shows how, by longitudinal sequencing, genotyping, and phenotyping. Congrats Glenn! @dariavantyne.bsky.social @aleciarokes.bsky.social journals.asm.org/doi/10.1128/...
journals.asm.org
Mutations leading to ceftolozane/tazobactam and imipenem/cilastatin/relebactam resistance during in vivo exposure to ceftazidime/avibactam in Pseudomonas aeruginosa | Microbiology Spectrum
Antibiotic resistance is a significant challenge for physicians trying to treat infections. The development of novel antibiotics to treat resistant infections has not been prioritized for decades, lim...
088
Daria Van Tyne @dariavantyne.bsky.social · 18/12/2024
I remember seeing Dr. O’Brien at seminars around Boston and Cambridge and being wowed at his stature, both physically and in the AMR field. And that was before I knew whose father he was… www.nejm.org/doi/abs/10.1...
nejm.org
A Tribute to Dr. Thomas J. O'Brien | NEJM
Original Article from The New England Journal of Medicine — A Tribute to Dr. Thomas J. O'Brien
010
Daria Van Tyne @dariavantyne.bsky.social · 10/12/2024
From our lab to yours, happy holidays!
090
Reposted by Daria Van Tyne
Jeremy Kamil @macroliter.bsky.social · 02/12/2024
🧪 Please share! Spring 2025 Microbiology & Immunology Diversity Scholars Program Applications open Dec 4-Jan 15. The program seeks to provide biomedical research opportunities for Pittsburgh area undergrads who are from underrepresented or disadvantaged backgrounds www.pmi.pitt.edu/research/mid...
pmi.pitt.edu
MID Scholars | Microbiology and Immunology | University of Pittsburgh
Microbiology and Immunology Diversity (MID) Scholars Program The purpose of this research program is to engage students from historically underrepresented or disadvantaged backgrounds in the biomedica...
02118
Reposted by Daria Van Tyne
Willem van Schaik @wvschaik.bsky.social · 12/11/2024
JOB CLAXON! I am recruiting a post-doctoral researcher on a BBSRC-funded project (36 months) on the genetics and functional genomics of vancomycin resistance in enterococci. Further details here: edzz.fa.em3.oraclecloud.com/hcmUI/Candid... Please DM or email me if you want to discuss this post.
edzz.fa.em3.oraclecloud.com
Research Fellow - Department of Microbes, Infections and Microbiomes - 104864 - Grade 7
This exciting BBSRC-funded project aims to mechanistically characterise the fitness costs associated with vancomycin resistance in the Gram-positive opportunistic pathogens Enterococcus faecalis and E...
04687
Daria Van Tyne @dariavantyne.bsky.social · 08/11/2024
Silver lining of an otherwise awful week: attending #RBM2024 with these fabulous folks. A great meeting full of awesome science!
1160
Reposted by Daria Van Tyne
Olaya Rendueles @olayarendueles.bsky.social · 14/11/2023
Check out this collection in the ASM journal Spectrum which highlights some recent advances on #Phagetherapy #MicroSky-with @dariavantyne.bsky.social journals.asm.org/phage-therap...
journals.asm.org
Phage Therapeutics
A collection of articles published by ASM Journals related to phage therapeutics.
042